冠状动脉疾病

血流储备分数指导下经皮冠状动脉介入治疗的


BACKGROUND

TheFractionalFlowReserveversusAngiographyforMultivesselEvaluation(FAME)2trialwasdesignedtotargetstenosescapableofinducingischemia(FFR,≤0.80)inalargemyocardialterritoryandtorefrainfromPCIinpatientswithhemodynamicallynonsignificantstenoses(FFR,0.80).

Wehypothesizedthatfractionalflowreserve(FFR)–guidedpercutaneouscoronaryintervention(PCI)wouldbesuperiortomedicaltherapyasinitialtreatmentinpatientswithstablecoronaryarterydisease.

背景

血流储备分数和血管造影用于多血管评估的比较(FractionalFlowReserveversusAngiographyforMultivesselEvaluation,FAME)2试验旨在靶向可诱导大面积心肌缺血(FFR≤0.80)的狭窄,并避免对血流动力学不显著(FFR>0.80)的狭窄患者进行PCI治疗。

我们假设,在稳定型冠心病患者中,作为初始治疗,血流储备分数(FFR)指导下的经皮冠状动脉介入治疗(PCI)优于药物治疗。

METHODS

Amongpatientswithangiographicallysignificantstenoses,thoseinwhomatleastonestenosiswashemodynamicallysignificant(FFR,≤0.80)wererandomlyassignedtoFFR-guidedPCIplusmedicaltherapyortomedicaltherapyalone.

PatientsinwhomallstenoseshadanFFRofmorethan0.80receivedmedicaltherapyandwereenteredintoaregistry.Theprimaryendpointwasa


转载请注明:http://www.ctongt.com/gbyz/4606.html


当前时间: